Treace Total Revenue from 2010 to 2024

TMCI Stock  USD 8.52  0.04  0.47%   
Treace Medical's Total Revenue is increasing with slightly volatile movements from year to year. Total Revenue is predicted to flatten to about 114.4 M. Total Revenue is the total amount of income generated by the sale of goods or services related to Treace Medical's primary operations. View All Fundamentals
 
Total Revenue  
First Reported
2010-12-31
Previous Quarter
187.1 M
Current Value
114.4 M
Quarterly Volatility
46.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Treace Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Treace Medical's main balance sheet or income statement drivers, such as Net Interest Income of 202.7 K, Interest Income of 5.6 M or Depreciation And Amortization of 2.8 M, as well as many indicators such as Price To Sales Ratio of 3.94, Dividend Yield of 0.0 or PTB Ratio of 5.34. Treace financial statements analysis is a perfect complement when working with Treace Medical Valuation or Volatility modules.
  
Check out the analysis of Treace Medical Correlation against competitors.

Latest Treace Medical's Total Revenue Growth Pattern

Below is the plot of the Total Revenue of Treace Medical Concepts over the last few years. Total revenue comprises all receipts Treace Medical Concepts generated from the sale of its products or services. It is the total amount of income generated by the sale of goods or services related to the company's primary operations. Treace Medical's Total Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Treace Medical's overall financial position and show how it may be relating to other accounts over time.
Total Revenue10 Years Trend
Slightly volatile
   Total Revenue   
       Timeline  

Treace Total Revenue Regression Statistics

Arithmetic Mean65,955,621
Geometric Mean55,572,477
Coefficient Of Variation71.02
Mean Deviation36,531,578
Median39,416,000
Standard Deviation46,840,245
Sample Variance2194T
Range147.7M
R-Value0.75
Mean Square Error1036.4T
R-Squared0.56
Significance0
Slope7,847,533
Total Sum of Squares30716.1T

Treace Total Revenue History

2024114.4 M
2023187.1 M
2022141.8 M
202194.4 M
202057.4 M

About Treace Medical Financial Statements

Investors use fundamental indicators, such as Treace Medical's Total Revenue, to determine how well the company is positioned to perform in the future. Although Treace Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Total Revenue187.1 M114.4 M

Currently Active Assets on Macroaxis

When determining whether Treace Medical Concepts offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Treace Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Treace Medical Concepts Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Treace Medical Concepts Stock:
Check out the analysis of Treace Medical Correlation against competitors.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Treace Medical. If investors know Treace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Treace Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.99)
Revenue Per Share
3.274
Quarterly Revenue Growth
0.106
Return On Assets
(0.17)
Return On Equity
(0.51)
The market value of Treace Medical Concepts is measured differently than its book value, which is the value of Treace that is recorded on the company's balance sheet. Investors also form their own opinion of Treace Medical's value that differs from its market value or its book value, called intrinsic value, which is Treace Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Treace Medical's market value can be influenced by many factors that don't directly affect Treace Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Treace Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Treace Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Treace Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.